

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.19241224 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.19241224 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.91252756 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.91252756 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.86965499 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.75506279 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.75506279 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.58171745 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57737594 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.48045291 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.43828413 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 5.32471407 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.25311607 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.22389390 |
| 15 | negative thymic T cell selection (GO:0045060) | 5.20795437 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.06295053 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.04472847 |
| 18 | negative T cell selection (GO:0043383) | 5.02076332 |
| 19 | tolerance induction (GO:0002507) | 5.01923412 |
| 20 | positive thymic T cell selection (GO:0045059) | 4.90019830 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.89897924 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.84734696 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.84734696 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.84734696 |
| 25 | thymic T cell selection (GO:0045061) | 4.78784681 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.76257857 |
| 27 | leukocyte aggregation (GO:0070486) | 4.76102137 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.74328533 |
| 29 | kynurenine metabolic process (GO:0070189) | 4.72222650 |
| 30 | bile acid biosynthetic process (GO:0006699) | 4.69902384 |
| 31 | tryptophan metabolic process (GO:0006568) | 4.59237111 |
| 32 | cysteine metabolic process (GO:0006534) | 4.59204009 |
| 33 | positive T cell selection (GO:0043368) | 4.52243400 |
| 34 | response to interleukin-15 (GO:0070672) | 4.50830834 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.45479139 |
| 36 | protein carboxylation (GO:0018214) | 4.45453592 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.45453592 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.41447523 |
| 39 | T cell selection (GO:0045058) | 4.41401128 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 4.38235879 |
| 41 | response to muramyl dipeptide (GO:0032495) | 4.37156810 |
| 42 | complement activation, alternative pathway (GO:0006957) | 4.35997372 |
| 43 | lysine metabolic process (GO:0006553) | 4.33573155 |
| 44 | lysine catabolic process (GO:0006554) | 4.33573155 |
| 45 | urea cycle (GO:0000050) | 4.32068577 |
| 46 | urea metabolic process (GO:0019627) | 4.32068577 |
| 47 | regulation of protein activation cascade (GO:2000257) | 4.31735113 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 4.27210023 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.22430934 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.19839432 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.16972034 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.13454852 |
| 53 | regulation of fibrinolysis (GO:0051917) | 4.10392002 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 4.10207387 |
| 55 | regulation of complement activation (GO:0030449) | 4.09544420 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.09443802 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.06451288 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.06120169 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.06120169 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.97519867 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 3.97462793 |
| 62 | bile acid metabolic process (GO:0008206) | 3.93723822 |
| 63 | glycine metabolic process (GO:0006544) | 3.93628618 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.92930373 |
| 65 | nitrogen cycle metabolic process (GO:0071941) | 3.91864736 |
| 66 | detection of bacterium (GO:0016045) | 3.90798723 |
| 67 | reverse cholesterol transport (GO:0043691) | 3.87150000 |
| 68 | phospholipid efflux (GO:0033700) | 3.87119841 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.84810794 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 3.84810794 |
| 71 | macromolecular complex remodeling (GO:0034367) | 3.84810794 |
| 72 | detection of other organism (GO:0098543) | 3.81749320 |
| 73 | valine metabolic process (GO:0006573) | 3.76846627 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.76366268 |
| 75 | ethanol oxidation (GO:0006069) | 3.75534449 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.74058534 |
| 77 | germinal center formation (GO:0002467) | 3.71446204 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 3.68046982 |
| 79 | alpha-amino acid catabolic process (GO:1901606) | 3.66624392 |
| 80 | serine family amino acid biosynthetic process (GO:0009070) | 3.66012027 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65015434 |
| 82 | triglyceride homeostasis (GO:0070328) | 3.64719901 |
| 83 | acylglycerol homeostasis (GO:0055090) | 3.64719901 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 3.63781372 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 3.63364379 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.63016292 |
| 87 | tyrosine metabolic process (GO:0006570) | 3.62274953 |
| 88 | amine catabolic process (GO:0009310) | 3.60589244 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 3.60589244 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 3.60494600 |
| 91 | T cell migration (GO:0072678) | 3.59562167 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.56618308 |
| 93 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56604303 |
| 94 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56604303 |
| 95 | modulation by symbiont of host immune response (GO:0052553) | 3.56604303 |
| 96 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56604303 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 3.56604303 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56604303 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 3.55398500 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.53653846 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.53653846 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53516010 |
| 103 | plasma lipoprotein particle assembly (GO:0034377) | 3.52472587 |
| 104 | cellular amino acid catabolic process (GO:0009063) | 3.47093573 |
| 105 | cellular glucuronidation (GO:0052695) | 3.45172792 |
| 106 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.41325191 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.40689479 |
| 108 | histone H3-K36 demethylation (GO:0070544) | 3.38912051 |
| 109 | activated T cell proliferation (GO:0050798) | 3.37308408 |
| 110 | mannose metabolic process (GO:0006013) | 3.37266541 |
| 111 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.36581725 |
| 112 | coenzyme catabolic process (GO:0009109) | 3.34213216 |
| 113 | fatty acid beta-oxidation (GO:0006635) | 3.30677324 |
| 114 | B cell receptor signaling pathway (GO:0050853) | 3.30414219 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 3.28216552 |
| 116 | indolalkylamine metabolic process (GO:0006586) | 3.28089970 |
| 117 | positive regulation of granulocyte differentiation (GO:0030854) | 3.27609347 |
| 118 | benzene-containing compound metabolic process (GO:0042537) | 3.27276713 |
| 119 | positive regulation of lipid catabolic process (GO:0050996) | 3.25780220 |
| 120 | urate metabolic process (GO:0046415) | 3.25095237 |
| 121 | negative regulation of innate immune response (GO:0045824) | 3.25062299 |
| 122 | bile acid and bile salt transport (GO:0015721) | 3.21322480 |
| 123 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.20837266 |
| 124 | regulation of plasminogen activation (GO:0010755) | 3.20772064 |
| 125 | cellular extravasation (GO:0045123) | 3.20519610 |
| 126 | fatty acid oxidation (GO:0019395) | 3.19200119 |
| 127 | response to type I interferon (GO:0034340) | 3.18805534 |
| 128 | cholesterol efflux (GO:0033344) | 3.18190320 |
| 129 | carnitine metabolic process (GO:0009437) | 3.17400058 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.17186490 |
| 131 | regulation of cholesterol metabolic process (GO:0090181) | 3.16934829 |
| 132 | cellular response to type I interferon (GO:0071357) | 3.16469365 |
| 133 | type I interferon signaling pathway (GO:0060337) | 3.16469365 |
| 134 | 2-oxoglutarate metabolic process (GO:0006103) | 3.15996152 |
| 135 | lipid oxidation (GO:0034440) | 3.15421771 |
| 136 | protein-lipid complex assembly (GO:0065005) | 3.15395501 |
| 137 | organic acid catabolic process (GO:0016054) | 3.15143130 |
| 138 | carboxylic acid catabolic process (GO:0046395) | 3.15143130 |
| 139 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.13006936 |
| 140 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.12817035 |
| 141 | plasma lipoprotein particle organization (GO:0071827) | 3.12799112 |
| 142 | fibrinolysis (GO:0042730) | 3.11310576 |
| 143 | regulation of B cell differentiation (GO:0045577) | 3.10119522 |
| 144 | regulation of tolerance induction (GO:0002643) | 3.10036389 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.10007549 |
| 146 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.10007549 |
| 147 | glutamate metabolic process (GO:0006536) | 3.07936933 |
| 148 | epoxygenase P450 pathway (GO:0019373) | 3.07275080 |
| 149 | response to nitrosative stress (GO:0051409) | 3.06883574 |
| 150 | monocarboxylic acid catabolic process (GO:0072329) | 3.06479294 |
| 151 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06361251 |
| 152 | short-chain fatty acid metabolic process (GO:0046459) | 3.06143978 |
| 153 | T cell homeostasis (GO:0043029) | 3.05763995 |
| 154 | fatty acid catabolic process (GO:0009062) | 3.03513489 |
| 155 | cholesterol homeostasis (GO:0042632) | 3.03226678 |
| 156 | lipoprotein metabolic process (GO:0042157) | 3.02891770 |
| 157 | B cell homeostasis (GO:0001782) | 3.02888681 |
| 158 | positive regulation of B cell differentiation (GO:0045579) | 3.02242201 |
| 159 | complement activation (GO:0006956) | 2.99799128 |
| 160 | negative regulation of interleukin-12 production (GO:0032695) | 2.99763571 |
| 161 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99696406 |
| 162 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.99493304 |
| 163 | detection of external biotic stimulus (GO:0098581) | 2.99437359 |
| 164 | glucuronate metabolic process (GO:0019585) | 2.98774428 |
| 165 | uronic acid metabolic process (GO:0006063) | 2.98774428 |
| 166 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98686062 |
| 167 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98686062 |
| 168 | sterol homeostasis (GO:0055092) | 2.96810911 |
| 169 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95099636 |
| 170 | lymphocyte homeostasis (GO:0002260) | 2.95024828 |
| 171 | defense response to protozoan (GO:0042832) | 2.93966587 |
| 172 | response to laminar fluid shear stress (GO:0034616) | 2.92508262 |
| 173 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91564156 |
| 174 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.91314873 |
| 175 | regulation of histone H3-K27 methylation (GO:0061085) | 2.90532564 |
| 176 | T cell receptor signaling pathway (GO:0050852) | 2.90081775 |
| 177 | neutrophil activation involved in immune response (GO:0002283) | 2.89641775 |
| 178 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.89277668 |
| 179 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88321846 |
| 180 | immunoglobulin mediated immune response (GO:0016064) | 2.85759040 |
| 181 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.84847745 |
| 182 | Peyers patch development (GO:0048541) | 2.84847745 |
| 183 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84508273 |
| 184 | natural killer cell differentiation (GO:0001779) | 2.84397536 |
| 185 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83965832 |
| 186 | positive regulation of tolerance induction (GO:0002645) | 2.81440780 |
| 187 | positive regulation of Rap GTPase activity (GO:0032854) | 2.80517083 |
| 188 | regulation of granulocyte differentiation (GO:0030852) | 2.76603333 |
| 189 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75279808 |
| 190 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75098413 |
| 191 | myeloid dendritic cell differentiation (GO:0043011) | 2.73583828 |
| 192 | negative regulation of bone resorption (GO:0045779) | 2.69947578 |
| 193 | negative regulation of type 2 immune response (GO:0002829) | 2.69839768 |
| 194 | alpha-beta T cell differentiation (GO:0046632) | 2.69425157 |
| 195 | positive regulation of interleukin-2 production (GO:0032743) | 2.66912146 |
| 196 | phospholipid scrambling (GO:0017121) | 2.65808498 |
| 197 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.65806182 |
| 198 | interferon-gamma production (GO:0032609) | 2.65750734 |
| 199 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.64717781 |
| 200 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.64655489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.59243462 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10013882 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.44603378 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.61740624 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.58349029 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.57336326 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.70880983 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.68107431 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.52298870 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99025632 |
| 11 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.72911534 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69975839 |
| 13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.59896091 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.59380969 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.43330311 |
| 16 | * MAF_26560356_Chip-Seq_TH2_Human | 2.32485764 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27725839 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26445624 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.22037407 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19293099 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.11366165 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09895388 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06532668 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02052164 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00979695 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88534712 |
| 27 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.87855485 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86040066 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84157560 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81251551 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71149593 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69541678 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67947451 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67611429 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67538663 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67505366 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62920997 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59844011 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55351736 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55052585 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.48956308 |
| 42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47886850 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45249988 |
| 44 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42352879 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40299138 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39626163 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38340818 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37795804 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37590526 |
| 50 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37429423 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35767195 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.31855899 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31830602 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30103232 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29665523 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29039278 |
| 57 | * P68_20966046_ChIP-Seq_HELA_Human | 1.29034640 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27411594 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24808128 |
| 60 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24600664 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24045528 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21068446 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19923188 |
| 64 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.19624479 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19357979 |
| 66 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18113118 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16944455 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15712271 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15504933 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14113856 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12514934 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11960082 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10587499 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07823728 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06404498 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04819885 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03358184 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02995056 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02729263 |
| 80 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02509666 |
| 81 | * MAF_26560356_Chip-Seq_TH1_Human | 1.02296319 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01991811 |
| 83 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01912929 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00959855 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99494531 |
| 86 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98783966 |
| 87 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98440362 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98403272 |
| 89 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97471124 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97227467 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96324573 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96146795 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95980801 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95371288 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94031739 |
| 96 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93775100 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93494709 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92090018 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92070254 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91770051 |
| 101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91443687 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90757106 |
| 103 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89753076 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89274097 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88973033 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88391892 |
| 107 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88286330 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87517697 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87153955 |
| 110 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86477933 |
| 111 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85846585 |
| 112 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85096959 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84824896 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84708942 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84401716 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82848294 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81848196 |
| 118 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80476240 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79944326 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79346509 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79043318 |
| 122 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.78708528 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77539102 |
| 124 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77464188 |
| 125 | MYB_26560356_Chip-Seq_TH1_Human | 0.77145074 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.76642730 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.76437659 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76132794 |
| 129 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.76020271 |
| 130 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.74274497 |
| 131 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73666213 |
| 132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73648948 |
| 133 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72997853 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72232196 |
| 135 | MYB_26560356_Chip-Seq_TH2_Human | 0.71556676 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71098290 |
| 137 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70488194 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70213353 |
| 139 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69873859 |
| 140 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69423065 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69396177 |
| 142 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.69165009 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68651086 |
| 144 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68322546 |
| 145 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.68220189 |
| 146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67636565 |
| 147 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67407497 |
| 148 | ATF3_27146783_Chip-Seq_COLON_Human | 0.66794622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.13075238 |
| 2 | MP0005360_urolithiasis | 5.64828633 |
| 3 | MP0005365_abnormal_bile_salt | 4.99694167 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.58815446 |
| 5 | MP0003763_abnormal_thymus_physiology | 4.05256738 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55308252 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.37803895 |
| 8 | MP0003252_abnormal_bile_duct | 3.10892718 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.84973359 |
| 10 | MP0009840_abnormal_foam_cell | 2.81308400 |
| 11 | MP0005671_abnormal_response_to | 2.79428272 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.68341934 |
| 13 | MP0003303_peritoneal_inflammation | 2.65760529 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.51065225 |
| 15 | MP0002723_abnormal_immune_serum | 2.46887629 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.43090174 |
| 17 | MP0001819_abnormal_immune_cell | 2.41501639 |
| 18 | MP0001873_stomach_inflammation | 2.37476053 |
| 19 | MP0005332_abnormal_amino_acid | 2.37341456 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.32583456 |
| 21 | MP0005083_abnormal_biliary_tract | 2.23115196 |
| 22 | MP0008260_abnormal_autophagy | 2.22197211 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.19071553 |
| 24 | MP0002398_abnormal_bone_marrow | 2.15214133 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.12983369 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.09953880 |
| 27 | MP0002405_respiratory_system_inflammati | 2.07764486 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.05621278 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 2.05493532 |
| 30 | MP0000716_abnormal_immune_system | 1.99991060 |
| 31 | MP0004381_abnormal_hair_follicle | 1.98177444 |
| 32 | MP0000609_abnormal_liver_physiology | 1.95044175 |
| 33 | MP0003866_abnormal_defecation | 1.93277533 |
| 34 | MP0003195_calcinosis | 1.91650897 |
| 35 | MP0005670_abnormal_white_adipose | 1.88254497 |
| 36 | MP0002722_abnormal_immune_system | 1.76411663 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.73728627 |
| 38 | MP0004510_myositis | 1.73561748 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.73279444 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.65283848 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.64198755 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.61049303 |
| 43 | MP0002429_abnormal_blood_cell | 1.59859320 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.57412434 |
| 45 | MP0005310_abnormal_salivary_gland | 1.51956857 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.50804108 |
| 47 | MP0003186_abnormal_redox_activity | 1.45218145 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.43203349 |
| 49 | MP0001851_eye_inflammation | 1.34534165 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32407179 |
| 51 | MP0003868_abnormal_feces_composition | 1.32087169 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.31222324 |
| 53 | MP0003436_decreased_susceptibility_to | 1.30795297 |
| 54 | MP0000685_abnormal_immune_system | 1.29226450 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.27870547 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.26482901 |
| 57 | MP0002254_reproductive_system_inflammat | 1.26269615 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.24778438 |
| 59 | MP0002009_preneoplasia | 1.23384371 |
| 60 | MP0000598_abnormal_liver_morphology | 1.22845519 |
| 61 | MP0000858_altered_metastatic_potential | 1.22199487 |
| 62 | MP0001764_abnormal_homeostasis | 1.19029403 |
| 63 | MP0009764_decreased_sensitivity_to | 1.18636422 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.17993516 |
| 65 | MP0003828_pulmonary_edema | 1.17222582 |
| 66 | MP0001853_heart_inflammation | 1.12280156 |
| 67 | MP0003011_delayed_dark_adaptation | 1.12005431 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.10931131 |
| 69 | MP0008469_abnormal_protein_level | 1.07819411 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.05425112 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 1.04962945 |
| 72 | MP0001849_ear_inflammation | 1.04880832 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.04414066 |
| 74 | MP0003724_increased_susceptibility_to | 1.03505149 |
| 75 | MP0009763_increased_sensitivity_to | 1.02932730 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.01110259 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.99921640 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.99146753 |
| 79 | MP0003279_aneurysm | 0.95848076 |
| 80 | MP0004883_abnormal_blood_vessel | 0.95450626 |
| 81 | MP0005023_abnormal_wound_healing | 0.92189026 |
| 82 | MP0002132_abnormal_respiratory_system | 0.91899527 |
| 83 | MP0001663_abnormal_digestive_system | 0.90881990 |
| 84 | MP0000490_abnormal_crypts_of | 0.90790809 |
| 85 | MP0003091_abnormal_cell_migration | 0.90683639 |
| 86 | MP0009697_abnormal_copulation | 0.90134800 |
| 87 | MP0002060_abnormal_skin_morphology | 0.89191576 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.88883393 |
| 89 | MP0003075_altered_response_to | 0.88514760 |
| 90 | MP0006054_spinal_hemorrhage | 0.85427584 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.83306479 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.83254841 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.82946744 |
| 94 | MP0005390_skeleton_phenotype | 0.81722886 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.80974372 |
| 96 | MP0001835_abnormal_antigen_presentation | 0.80645627 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.78611798 |
| 98 | MP0009053_abnormal_anal_canal | 0.77844481 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.77185684 |
| 100 | MP0003448_altered_tumor_morphology | 0.76913298 |
| 101 | MP0009785_altered_susceptibility_to | 0.76643294 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.75806211 |
| 103 | MP0005275_abnormal_skin_tensile | 0.74771077 |
| 104 | MP0005451_abnormal_body_composition | 0.74601086 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.74308277 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.74228503 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.73846904 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.73721889 |
| 109 | MP0003795_abnormal_bone_structure | 0.73686737 |
| 110 | MP0003045_fibrosis | 0.73161463 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.72802048 |
| 112 | MP0008995_early_reproductive_senescence | 0.71208522 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.71060782 |
| 114 | MP0004130_abnormal_muscle_cell | 0.70889169 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.70712273 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.70712273 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.70168034 |
| 118 | MP0002928_abnormal_bile_duct | 0.69946088 |
| 119 | MP0005166_decreased_susceptibility_to | 0.68002154 |
| 120 | MP0005647_abnormal_sex_gland | 0.67304462 |
| 121 | MP0009278_abnormal_bone_marrow | 0.66922408 |
| 122 | MP0002971_abnormal_brown_adipose | 0.66508588 |
| 123 | MP0002006_tumorigenesis | 0.66219110 |
| 124 | MP0005025_abnormal_response_to | 0.66104828 |
| 125 | MP0004947_skin_inflammation | 0.65851294 |
| 126 | MP0005334_abnormal_fat_pad | 0.65652749 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.65325499 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.64702676 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.64608781 |
| 130 | MP0002249_abnormal_larynx_morphology | 0.64168788 |
| 131 | MP0001756_abnormal_urination | 0.63614603 |
| 132 | MP0002419_abnormal_innate_immunity | 0.61900415 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.60862363 |
| 134 | MP0009115_abnormal_fat_cell | 0.60327835 |
| 135 | MP0000604_amyloidosis | 0.59949259 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.59710662 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.59526104 |
| 138 | MP0000249_abnormal_blood_vessel | 0.58812227 |
| 139 | MP0001800_abnormal_humoral_immune | 0.58724731 |
| 140 | MP0003690_abnormal_glial_cell | 0.58533418 |
| 141 | MP0008004_abnormal_stomach_pH | 0.58368540 |
| 142 | MP0005164_abnormal_response_to | 0.57489284 |
| 143 | MP0006036_abnormal_mitochondrial_physio | 0.56986330 |
| 144 | MP0005535_abnormal_body_temperature | 0.56638270 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.56411323 |
| 146 | MP0005381_digestive/alimentary_phenotyp | 0.56239641 |
| 147 | MP0010352_gastrointestinal_tract_polyps | 0.56131434 |
| 148 | MP0001243_abnormal_dermal_layer | 0.55111938 |
| 149 | MP0000371_diluted_coat_color | 0.54528608 |
| 150 | MP0001790_abnormal_immune_system | 0.54473297 |
| 151 | MP0005387_immune_system_phenotype | 0.54473297 |
| 152 | MP0002933_joint_inflammation | 0.54464988 |
| 153 | MP0002168_other_aberrant_phenotype | 0.53849102 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.53072307 |
| 155 | MP0000767_abnormal_smooth_muscle | 0.52706918 |
| 156 | MP0006082_CNS_inflammation | 0.52553271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.57197699 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.00203780 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.80930706 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.75943942 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.43755136 |
| 6 | Xanthomatosis (HP:0000991) | 5.36759002 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.84720605 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.74087812 |
| 9 | Pustule (HP:0200039) | 4.52673785 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.43419944 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.38835099 |
| 12 | Myositis (HP:0100614) | 4.33772787 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.24463929 |
| 14 | Complement deficiency (HP:0004431) | 4.19294198 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00908253 |
| 16 | Increased IgE level (HP:0003212) | 4.00521860 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.96310001 |
| 18 | Obstructive sleep apnea (HP:0002870) | 3.95505138 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.92153704 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.91358607 |
| 21 | Ketosis (HP:0001946) | 3.88563429 |
| 22 | Hyperammonemia (HP:0001987) | 3.83837280 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82438835 |
| 24 | Stomatitis (HP:0010280) | 3.75260027 |
| 25 | Orchitis (HP:0100796) | 3.71173142 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.70223157 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.69307479 |
| 28 | Joint hemorrhage (HP:0005261) | 3.68138657 |
| 29 | Hyperglycinuria (HP:0003108) | 3.67613209 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.65754730 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 3.59505742 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.56994020 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.49024691 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.47730949 |
| 35 | Optic neuritis (HP:0100653) | 3.47730949 |
| 36 | Meningitis (HP:0001287) | 3.45754243 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.44103923 |
| 38 | Hyperglycinemia (HP:0002154) | 3.43881304 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.42158211 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41335702 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.39362561 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 3.39362561 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34794405 |
| 44 | T lymphocytopenia (HP:0005403) | 3.34696196 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.31027015 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 3.30591571 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29537919 |
| 48 | Fat malabsorption (HP:0002630) | 3.23058834 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 3.21383983 |
| 50 | Epidermoid cyst (HP:0200040) | 3.20628528 |
| 51 | Abnormality of complement system (HP:0005339) | 3.19329993 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 3.18059412 |
| 53 | Abnormality of the fingertips (HP:0001211) | 3.17553598 |
| 54 | Myocardial infarction (HP:0001658) | 3.17190447 |
| 55 | Vasculitis (HP:0002633) | 3.12383502 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11082765 |
| 57 | Obstructive lung disease (HP:0006536) | 3.11082765 |
| 58 | Spontaneous hematomas (HP:0007420) | 3.10022286 |
| 59 | Prolonged bleeding time (HP:0003010) | 3.08551081 |
| 60 | Abnormality of T cell number (HP:0011839) | 3.06248302 |
| 61 | Ketoacidosis (HP:0001993) | 3.04297793 |
| 62 | Hypercholesterolemia (HP:0003124) | 3.02641556 |
| 63 | Recurrent viral infections (HP:0004429) | 3.02557797 |
| 64 | Encephalitis (HP:0002383) | 2.95467920 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.95156032 |
| 66 | Cellulitis (HP:0100658) | 2.93603493 |
| 67 | Gingivitis (HP:0000230) | 2.92824762 |
| 68 | Verrucae (HP:0200043) | 2.91805614 |
| 69 | Papilloma (HP:0012740) | 2.91805614 |
| 70 | Granulocytopenia (HP:0001913) | 2.87063678 |
| 71 | Abnormality of T cells (HP:0002843) | 2.85608762 |
| 72 | Colitis (HP:0002583) | 2.84269109 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84239131 |
| 74 | Papilledema (HP:0001085) | 2.83392300 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83265709 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83265709 |
| 77 | Broad face (HP:0000283) | 2.83224411 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.82844037 |
| 79 | Lymphopenia (HP:0001888) | 2.82349166 |
| 80 | Spastic diplegia (HP:0001264) | 2.80173799 |
| 81 | Hyperbilirubinemia (HP:0002904) | 2.76417167 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.73613349 |
| 83 | Seborrheic dermatitis (HP:0001051) | 2.68298134 |
| 84 | Chest pain (HP:0100749) | 2.63703858 |
| 85 | Abnormality of purine metabolism (HP:0004352) | 2.60845189 |
| 86 | Severe combined immunodeficiency (HP:0004430) | 2.59995155 |
| 87 | Recurrent skin infections (HP:0001581) | 2.59596198 |
| 88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.58955656 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.58469990 |
| 90 | Basal cell carcinoma (HP:0002671) | 2.57987036 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.56527360 |
| 92 | Esophageal varix (HP:0002040) | 2.55075766 |
| 93 | Late onset (HP:0003584) | 2.54669426 |
| 94 | Hepatocellular carcinoma (HP:0001402) | 2.54228418 |
| 95 | Generalized aminoaciduria (HP:0002909) | 2.52989908 |
| 96 | Delayed CNS myelination (HP:0002188) | 2.49351539 |
| 97 | Hemoptysis (HP:0002105) | 2.49072011 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.47777856 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.47496582 |
| 100 | Agammaglobulinemia (HP:0004432) | 2.45403400 |
| 101 | Steatorrhea (HP:0002570) | 2.44992355 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44394529 |
| 103 | Thin bony cortex (HP:0002753) | 2.43096875 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.42593925 |
| 105 | Alopecia of scalp (HP:0002293) | 2.41135576 |
| 106 | Leukocytosis (HP:0001974) | 2.38902542 |
| 107 | Gingival bleeding (HP:0000225) | 2.38811506 |
| 108 | Slow saccadic eye movements (HP:0000514) | 2.34777221 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34184557 |
| 110 | Dicarboxylic aciduria (HP:0003215) | 2.34184557 |
| 111 | Hypoglycemic seizures (HP:0002173) | 2.34102557 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.33831289 |
| 113 | Hydroxyprolinuria (HP:0003080) | 2.33831289 |
| 114 | Emphysema (HP:0002097) | 2.32915688 |
| 115 | Mitral stenosis (HP:0001718) | 2.32487576 |
| 116 | Increased IgM level (HP:0003496) | 2.31552226 |
| 117 | Hypochromic anemia (HP:0001931) | 2.31046911 |
| 118 | Keratoconjunctivitis (HP:0001096) | 2.30199706 |
| 119 | Spinal canal stenosis (HP:0003416) | 2.27191197 |
| 120 | Recurrent bronchitis (HP:0002837) | 2.25507232 |
| 121 | Gout (HP:0001997) | 2.25171152 |
| 122 | Premature loss of primary teeth (HP:0006323) | 2.22097874 |
| 123 | Amyloidosis (HP:0011034) | 2.21501373 |
| 124 | Osteomyelitis (HP:0002754) | 2.21421456 |
| 125 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19740973 |
| 126 | Abnormality of serum amino acid levels (HP:0003112) | 2.19343018 |
| 127 | Skin nodule (HP:0200036) | 2.17362474 |
| 128 | Menorrhagia (HP:0000132) | 2.16701262 |
| 129 | Easy fatigability (HP:0003388) | 2.16408850 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 2.15595077 |
| 131 | Eosinophilia (HP:0001880) | 2.15588264 |
| 132 | Glomerulonephritis (HP:0000099) | 2.15006323 |
| 133 | IgM deficiency (HP:0002850) | 2.14996834 |
| 134 | Thrombophlebitis (HP:0004418) | 2.14846728 |
| 135 | Metabolic acidosis (HP:0001942) | 2.10950397 |
| 136 | Protrusio acetabuli (HP:0003179) | 2.10037327 |
| 137 | Hypergammaglobulinemia (HP:0010702) | 2.09985731 |
| 138 | Restrictive lung disease (HP:0002091) | 2.09843966 |
| 139 | Pulmonary embolism (HP:0002204) | 2.09765952 |
| 140 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09715978 |
| 141 | Nausea (HP:0002018) | 2.08272608 |
| 142 | Viral hepatitis (HP:0006562) | 2.07186112 |
| 143 | Vascular calcification (HP:0004934) | 2.03101274 |
| 144 | Spontaneous abortion (HP:0005268) | 2.01253685 |
| 145 | Combined immunodeficiency (HP:0005387) | 2.00716437 |
| 146 | Hypertriglyceridemia (HP:0002155) | 1.98313345 |
| 147 | Polycythemia (HP:0001901) | 1.97815476 |
| 148 | Dislocated radial head (HP:0003083) | 1.96792827 |
| 149 | Abnormality of eosinophils (HP:0001879) | 1.96615309 |
| 150 | Cardiovascular calcification (HP:0011915) | 1.96408490 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.95934973 |
| 152 | Pancreatitis (HP:0001733) | 1.95433748 |
| 153 | Nephritis (HP:0000123) | 1.95061254 |
| 154 | Urticaria (HP:0001025) | 1.94793970 |
| 155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94304860 |
| 156 | Hypochromic microcytic anemia (HP:0004840) | 1.93265209 |
| 157 | Subacute progressive viral hepatitis (HP:0006572) | 1.92981281 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92559405 |
| 159 | Enlarged kidneys (HP:0000105) | 1.91875927 |
| 160 | Dysostosis multiplex (HP:0000943) | 1.90451991 |
| 161 | Ectopia lentis (HP:0001083) | 1.89234400 |
| 162 | Peritonitis (HP:0002586) | 1.88595422 |
| 163 | Metaphyseal cupping (HP:0003021) | 1.88565457 |
| 164 | Turricephaly (HP:0000262) | 1.88280042 |
| 165 | IgG deficiency (HP:0004315) | 1.87474309 |
| 166 | Neonatal onset (HP:0003623) | 1.87237658 |
| 167 | Abnormality of the pleura (HP:0002103) | 1.87195452 |
| 168 | J-shaped sella turcica (HP:0002680) | 1.85490087 |
| 169 | Irritability (HP:0000737) | 1.85311869 |
| 170 | Abnormality of the radial head (HP:0003995) | 1.85199199 |
| 171 | Epistaxis (HP:0000421) | 1.85116579 |
| 172 | Hemorrhage of the eye (HP:0011885) | 1.84718955 |
| 173 | Teleangiectasia of the skin (HP:0100585) | 1.84527891 |
| 174 | Opisthotonus (HP:0002179) | 1.83676219 |
| 175 | Stomach cancer (HP:0012126) | 1.83056602 |
| 176 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82642653 |
| 177 | Sepsis (HP:0100806) | 1.82349067 |
| 178 | Biconcave vertebral bodies (HP:0004586) | 1.82302507 |
| 179 | Arterial thrombosis (HP:0004420) | 1.81871564 |
| 180 | Cervical subluxation (HP:0003308) | 1.81754068 |
| 181 | Recurrent sinusitis (HP:0011108) | 1.81713270 |
| 182 | Interstitial pulmonary disease (HP:0006530) | 1.80917402 |
| 183 | Lethargy (HP:0001254) | 1.80424182 |
| 184 | Increased mean platelet volume (HP:0011877) | 1.78816851 |
| 185 | Skin ulcer (HP:0200042) | 1.78523278 |
| 186 | Episodic fever (HP:0001954) | 1.78260763 |
| 187 | Autoimmune hemolytic anemia (HP:0001890) | 1.78194684 |
| 188 | Impaired platelet aggregation (HP:0003540) | 1.77630960 |
| 189 | Abnormal platelet function (HP:0011869) | 1.77630960 |
| 190 | Malnutrition (HP:0004395) | 1.77423469 |
| 191 | Increased serum ferritin (HP:0003281) | 1.77144011 |
| 192 | Mesangial abnormality (HP:0001966) | 1.73734909 |
| 193 | Stroke (HP:0001297) | 1.73645312 |
| 194 | Back pain (HP:0003418) | 1.72114904 |
| 195 | Abnormal platelet volume (HP:0011876) | 1.70135872 |
| 196 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.69502823 |
| 197 | Elevated hepatic transaminases (HP:0002910) | 1.69178248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.96945541 |
| 2 | BCKDK | 4.38339040 |
| 3 | TRIB3 | 3.44571671 |
| 4 | SIK1 | 3.41927152 |
| 5 | PRPF4B | 3.28837014 |
| 6 | FGFR4 | 3.28322013 |
| 7 | FLT3 | 3.09009626 |
| 8 | SIK3 | 2.74783255 |
| 9 | RIPK4 | 2.65611586 |
| 10 | PKN2 | 2.61282749 |
| 11 | TNK2 | 2.25657212 |
| 12 | MAP3K10 | 2.11563566 |
| 13 | SIK2 | 2.06240026 |
| 14 | IRAK4 | 2.04479634 |
| 15 | TYK2 | 1.94294285 |
| 16 | MAP4K1 | 1.80792516 |
| 17 | SMG1 | 1.76531602 |
| 18 | EEF2K | 1.72184781 |
| 19 | PTK6 | 1.66256203 |
| 20 | MAPK11 | 1.64205611 |
| 21 | KIT | 1.59934657 |
| 22 | FES | 1.58314715 |
| 23 | TGFBR2 | 1.58232668 |
| 24 | JAK3 | 1.57414987 |
| 25 | BLK | 1.53662944 |
| 26 | TBK1 | 1.50143816 |
| 27 | MARK2 | 1.49287769 |
| 28 | TAOK3 | 1.46293363 |
| 29 | LRRK2 | 1.41031738 |
| 30 | HCK | 1.40688534 |
| 31 | PIK3CG | 1.38488756 |
| 32 | MAP2K3 | 1.36438479 |
| 33 | CAMKK1 | 1.30891452 |
| 34 | NME2 | 1.28662616 |
| 35 | ZAP70 | 1.22022883 |
| 36 | CAMK1D | 1.20133352 |
| 37 | MARK3 | 1.19909939 |
| 38 | PDGFRA | 1.16741075 |
| 39 | CDC42BPA | 1.16144414 |
| 40 | LCK | 1.15237904 |
| 41 | BTK | 1.14590108 |
| 42 | MAPK15 | 1.14460560 |
| 43 | STK10 | 1.13992061 |
| 44 | MAP3K7 | 1.13727003 |
| 45 | MAP3K3 | 1.13070124 |
| 46 | KDR | 1.13021224 |
| 47 | HIPK2 | 1.10389483 |
| 48 | GRK6 | 1.10010492 |
| 49 | CSF1R | 1.09768065 |
| 50 | RIPK1 | 1.08828972 |
| 51 | MAP3K1 | 1.08101582 |
| 52 | TGFBR1 | 1.07021799 |
| 53 | IRAK1 | 1.06915729 |
| 54 | EPHA3 | 1.06415188 |
| 55 | SYK | 1.03541225 |
| 56 | MAP3K14 | 1.03383099 |
| 57 | JAK1 | 1.02921949 |
| 58 | PRKD2 | 1.00945638 |
| 59 | RPS6KA4 | 0.99129495 |
| 60 | CDK6 | 0.98912746 |
| 61 | INSRR | 0.97186458 |
| 62 | TAOK1 | 0.96246519 |
| 63 | PIM2 | 0.95236898 |
| 64 | LATS1 | 0.93666594 |
| 65 | MAPK7 | 0.92380166 |
| 66 | BRD4 | 0.88785490 |
| 67 | PASK | 0.87622414 |
| 68 | NEK9 | 0.86525532 |
| 69 | DYRK1B | 0.86479054 |
| 70 | MAPK12 | 0.85564252 |
| 71 | TTN | 0.85336499 |
| 72 | MST1R | 0.85331628 |
| 73 | IKBKB | 0.85135480 |
| 74 | CDK4 | 0.84905430 |
| 75 | JAK2 | 0.84802798 |
| 76 | CDK12 | 0.84035293 |
| 77 | EPHB1 | 0.83227178 |
| 78 | FGFR3 | 0.82904839 |
| 79 | IKBKE | 0.81879908 |
| 80 | CHUK | 0.78790782 |
| 81 | TAOK2 | 0.77478319 |
| 82 | MAP3K6 | 0.77114288 |
| 83 | IRAK2 | 0.76916520 |
| 84 | TYRO3 | 0.72544669 |
| 85 | CSK | 0.72498187 |
| 86 | PIM1 | 0.72157668 |
| 87 | ICK | 0.70093411 |
| 88 | EPHB2 | 0.68479037 |
| 89 | PAK4 | 0.67944035 |
| 90 | CAMKK2 | 0.65688312 |
| 91 | BMX | 0.65528845 |
| 92 | LMTK2 | 0.64865554 |
| 93 | PDK1 | 0.64399162 |
| 94 | TEC | 0.64197069 |
| 95 | MTOR | 0.63348942 |
| 96 | MATK | 0.62946407 |
| 97 | MAP3K11 | 0.62771279 |
| 98 | PTK2 | 0.62139031 |
| 99 | KSR2 | 0.61549091 |
| 100 | NLK | 0.61279014 |
| 101 | PRKAA2 | 0.60715378 |
| 102 | RET | 0.57850797 |
| 103 | MAP2K2 | 0.57651087 |
| 104 | TIE1 | 0.56868938 |
| 105 | RPS6KL1 | 0.56715590 |
| 106 | RPS6KC1 | 0.56715590 |
| 107 | ITK | 0.56312763 |
| 108 | MAP2K6 | 0.56264921 |
| 109 | PAK2 | 0.56221481 |
| 110 | MAPK4 | 0.54556214 |
| 111 | FGR | 0.54073771 |
| 112 | IRAK3 | 0.53954522 |
| 113 | RPS6KB2 | 0.53593128 |
| 114 | PDGFRB | 0.52758231 |
| 115 | STK3 | 0.51027094 |
| 116 | FGFR2 | 0.50167116 |
| 117 | MAP3K8 | 0.48175715 |
| 118 | PDPK1 | 0.47264275 |
| 119 | MELK | 0.47001725 |
| 120 | SCYL2 | 0.46986397 |
| 121 | MAPKAPK3 | 0.46962036 |
| 122 | TXK | 0.46335607 |
| 123 | DDR2 | 0.46286200 |
| 124 | RPS6KA6 | 0.45668933 |
| 125 | ACVR1B | 0.45358878 |
| 126 | CDK7 | 0.44338531 |
| 127 | PRKG2 | 0.42958260 |
| 128 | CAMK4 | 0.42245113 |
| 129 | MET | 0.41851181 |
| 130 | GSK3A | 0.41349468 |
| 131 | FYN | 0.41186235 |
| 132 | YES1 | 0.41120427 |
| 133 | SGK3 | 0.40332975 |
| 134 | DYRK3 | 0.39607291 |
| 135 | CAMK1G | 0.39416742 |
| 136 | ERBB2 | 0.39087279 |
| 137 | ABL2 | 0.38929771 |
| 138 | PRKCQ | 0.38617417 |
| 139 | LYN | 0.37954057 |
| 140 | BRSK1 | 0.37875019 |
| 141 | STK38 | 0.37785394 |
| 142 | FGFR1 | 0.36608753 |
| 143 | IGF1R | 0.36036831 |
| 144 | MAP3K13 | 0.35517306 |
| 145 | ERBB4 | 0.35394580 |
| 146 | PRKCH | 0.32430315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93511252 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32922848 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.22331459 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85100696 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75405684 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57252601 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49122042 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.47990077 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46485257 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42232287 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41666061 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41045794 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.40278055 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34536717 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33199265 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.29776425 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.28928033 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 2.10825048 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07630026 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.03298849 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03051504 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02916905 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02834113 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99397632 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93396151 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92592207 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85868656 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85738893 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84121683 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82109456 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77240224 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75811609 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75424961 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69305444 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69029111 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68140944 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65544679 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62918852 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60384288 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57896292 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56722524 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55233375 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.53414548 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51799914 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.49343829 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46660724 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42286093 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42270849 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40977910 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.40972855 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40443209 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.40205421 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38453617 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37862721 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37114749 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.35400389 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34862556 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34615391 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.33811807 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 1.31098926 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30379402 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.29996356 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28792352 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25757382 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25603332 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25090277 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22154105 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22067873 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21874664 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19369135 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19077174 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18236548 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16300367 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15102568 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 1.13363477 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13061262 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.12904974 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12614891 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12539411 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 1.12243032 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 1.11616084 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11127424 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 1.10851813 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.09081328 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08020600 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05795650 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04944001 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03673750 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01471945 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99872571 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99635009 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99521930 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.99489344 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98148979 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97807642 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96069221 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95720554 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.92724941 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88662945 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88599155 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88587773 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88358738 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87557343 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86563121 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83940474 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83462245 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.80407608 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.79610173 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79227087 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78303499 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77645430 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75704945 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74903663 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74501143 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74253606 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.73232738 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73037338 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72923878 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66498248 |
| 120 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65581121 |
| 121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65401715 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.65016573 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62586344 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62392788 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61899753 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61852800 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60760231 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60238902 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.60139749 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58944077 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58227834 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58072988 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56613545 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55603658 |
| 135 | Glioma_Homo sapiens_hsa05214 | 0.54783570 |
| 136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53626485 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52497237 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.52080619 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47574251 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46925793 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46259248 |
| 142 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45571184 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43480398 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41381607 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41216367 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41213201 |
| 147 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41201001 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.39823934 |
| 149 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37313323 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32162863 |
| 151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31941481 |
| 152 | Legionellosis_Homo sapiens_hsa05134 | 0.31528318 |
| 153 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28547159 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27644554 |
| 155 | Prion diseases_Homo sapiens_hsa05020 | 0.24752727 |
| 156 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24320872 |
| 157 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19525623 |
| 158 | Bladder cancer_Homo sapiens_hsa05219 | 0.18556009 |
| 159 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.18493662 |
| 160 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16362690 |
| 161 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.15315194 |
| 162 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.15196707 |
| 163 | Malaria_Homo sapiens_hsa05144 | 0.14226245 |
| 164 | DNA replication_Homo sapiens_hsa03030 | 0.11903358 |
| 165 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10878801 |
| 166 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10311314 |
| 167 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10305162 |
| 168 | Thyroid cancer_Homo sapiens_hsa05216 | 0.09607924 |
| 169 | Base excision repair_Homo sapiens_hsa03410 | 0.09283664 |
| 170 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.09144224 |
| 171 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08881943 |
| 172 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.08711058 |
| 173 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.08491755 |
| 174 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.08072605 |
| 175 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08015670 |
| 176 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.05986237 |
| 177 | Hepatitis C_Homo sapiens_hsa05160 | 0.05450080 |
| 178 | Measles_Homo sapiens_hsa05162 | 0.04374579 |
| 179 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.03638621 |
| 180 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.03163307 |

